Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.250
-0.070 (-3.02%)
Mar 31, 2025, 3:54 PM EDT - Market open
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $30.87 million as of March 31, 2025. Its market cap has decreased by -3.42% in one year.
Market Cap
30.87M
Enterprise Value
20.77M
1-Year Change
-3.42%
Ranking
Category
Stock Price
2.25
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $30.87M, a decrease of -64.61%. That is a compound annual growth rate of -7.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |